CAS 871026-44-7

TAK 285

Description:

TAK-285, with the CAS number 871026-44-7, is a small molecule that functions primarily as a selective inhibitor of certain receptor tyrosine kinases, particularly those involved in cancer signaling pathways. It is characterized by its ability to interfere with the phosphorylation processes that are crucial for cell proliferation and survival, making it a subject of interest in cancer research and therapeutic development. TAK-285 exhibits a specific binding affinity for its target kinases, which can lead to the inhibition of tumor growth in various cancer models. The compound is typically studied in the context of its pharmacokinetics, efficacy, and safety profile, as well as its potential applications in targeted cancer therapies. Additionally, its chemical structure includes functional groups that contribute to its biological activity and solubility properties. As with many investigational drugs, ongoing research aims to elucidate its full therapeutic potential and mechanisms of action in oncology.

Formula: C₂₆H₂₅ClF₃N₅O₃

Synonyms:

• N-[2-[4-[[3-Chloro-4-[3-(trifluoromethyl)phenoxy]phenyl]amino]-5H-pyrrolo[3,2-d]pyrimidin-5-yl]ethyl]-3-hydroxy-3-methylbutanamide
• TAK-285

TAK-285

CAS: 871026-44-7

Formula: C₂₆H₂₅ClF₃N₅O₃

Purity: 99%

Color and Shape: Solid

Molecular weight: 547.9566

Ref: IN-DA00GU6M

TAK-285

CAS: 871026-44-7

TAK-285

Purity: ≥98%

Molecular weight: 547.96g/mol

Ref: 54-BUP04912

TAK-285

CAS: 871026-44-7

Ref: 7W-GW3736

TAK-285

CAS: 871026-44-7

TAK-285 is a novel dual HER2 and EGFR(HER1) inhibitor, >10-fold selectivity for HER1/2 than HER4, less potent to MEK1/5, c-Met, Aurora B, Lck, CSK etc.

Formula: C₂₆H₂₅ClF₃N₅O₃

Purity: 99.73%

Color and Shape: Solid

Molecular weight: 547.96

Ref: TM-T6039

TAK 285

CAS: 871026-44-7

Inhibitor of HER2/EGFR receptor

Formula: C₂₆H₂₅ClF₃N₅O₃

Purity: Min. 95%

Molecular weight: 547.96 g/mol

Ref: 3D-FT103851